Skip to content

Assessing the effect of supplemental injectable progesterone on complicated monochorionic diamnionic twin pregnanciy with radiofrequency ablation with cercival length of 25 mm or above on TVS

Assessing the effect of supplemental injectable progesterone on complicated monochorionic diamnionic twin pregnanciy with radiofrequency ablation with cercival length of 25 mm or above on TVS

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200215046496N1
Enrollment
80
Registered
2020-03-24
Start date
2019-03-17
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

complicated monochorionic diamnionic twin pregnancy.

Interventions

Intervention 1: Intervention group:  monochorionic twin pregnancies complicated with anomalous fetus or selective IUGR of a co-twin with cervical length more than 25 millimeters undergoing radiofreque

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: complicated monochorionic diamnionic twin pregnanciy with radiofrequency ablation with cercival length of 25 mm or above on TVS intrauterine growth restriction or anomaly of one of the twins

Exclusion criteria

Exclusion criteria: personal history of cervical insufficiency or second trimester recurrent pregnancy loos history of preterm delivery in previous pregnancies cerclage twin-twin transfusion syndrome (TTTS)

Design outcomes

Primary

MeasureTime frame
Decreasing rate of preterm delivery. Timepoint: termination of pregnancy. Method of measurement: tele-follow up.

Secondary

MeasureTime frame
Neonate admission to NICU. Timepoint: after delivery. Method of measurement: tele-follow up.;Preterm premature rupture of membranes. Timepoint: termination of pregnancy. Method of measurement: tele-follow up.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFough-o-Zaman Jabbari

Tehran University of Medical Sciences

forouq.jabbari@gmail.com+98 21 4216 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026